Page last updated: 2024-09-03
celastrol and Respiratory Distress Syndrome
celastrol has been researched along with Respiratory Distress Syndrome in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bi, Z; Chen, L; He, C; Hong, W; Lan, T; Luo, M; Que, H; Ren, W; Wan, D; Wei, X; Yang, J; Zeng, H; Zhong, A | 1 |
Wang, Y; Wei, Y | 1 |
Other Studies
2 other study(ies) available for celastrol and Respiratory Distress Syndrome
Article | Year |
---|---|
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment.
Topics: Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Liposomes; Mice; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
Celastrol attenuates impairments associated with lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) in rats.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Medicine, Chinese Traditional; NF-kappa B; Pentacyclic Triterpenes; Rats; Rats, Wistar; Respiratory Distress Syndrome; Triterpenes | 2017 |